Preclinical data presented for a novel cross-linking dependent 4-1BB agonist antibody, PE-0116 April 10, 2019
First patient enrolled in phase I/II study of NanoDoce for the treatment of bladder cancer April 10, 2019
First-in-human data for PLN-74809 support development of the candidate for the treatment of IPF April 10, 2019
RSS